Kynamro carries a Boxed Warning on the serious risk of liver toxicity because it is associated with liver enzyme abnormalities and accumulation of fat in the liver, which could lead to progressive liver disease with chronic use.
FORBES: FDA Approves Mipomersen For Homozygous Familial Hypercholesterolemia